Found 245 matching trials
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse PHASE3 Prospective, multi-center, randomized, open label comparative Phase III stu...
Show More Location
University Clinic Ulm
Learn More & Join Trial
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration N/A In this study, investigators utilize a radiopathomics integrated Artificial...
Show More Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Adj TC + Herceptin Early Stage Breast Cancer PHASE2 The purpose of this research study is to find out what effects (good and ba...
Show More Location
Birmingham Hematology and Oncology
Learn More & Join Trial
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer PHASE2 The investigators plan to carry out a phase II, open-label, single-arm clin...
Show More Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Learn More & Join Trial
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients PHASE3 Breast cancer is the most common malignant tumor in women. Recurrent or met...
Show More Learn More & Join Trial
Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer PHASE2 This trial is a multicenter, open-label, phase II trial conducted at 23 cen...
Show More Learn More & Join Trial
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer PHASE2 This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer PHASE3 This is an open label, phase III study evaluating the efficacy and safety o...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer PHASE2 This research study is studying an investigational drug as a possible treat...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial